» Articles » PMID: 20141519

Facts, Fancies and Follies of Drug-induced QT/QTc Interval Shortening

Overview
Journal Br J Pharmacol
Publisher Wiley
Specialty Pharmacology
Date 2010 Feb 10
PMID 20141519
Citations 10
Authors
Affiliations
Soon will be listed here.
Citing Articles

Mapping the Knowledge of Antipsychotics-Induced Sudden Cardiac Death: A Scientometric Analysis in CiteSpace and VOSviewer.

Wang M, Ma Y, Shen Z, Jiang L, Zhang X, Wei X Front Psychiatry. 2022; 13:925583.

PMID: 35873271 PMC: 9300900. DOI: 10.3389/fpsyt.2022.925583.


A thorough QTc study to evaluate the effects of oral rilzabrutinib administered alone and with ritonavir in healthy subjects.

Ucpinar S, Darpo B, Neale A, Nunn P, Shu J, Chu K Clin Transl Sci. 2022; 15(6):1507-1518.

PMID: 35301810 PMC: 9199881. DOI: 10.1111/cts.13271.


Confirmation of the cardiac safety of nolasiban in a randomised cohort of healthy female volunteers.

Taubel J, Lorch U, Spencer C, Freier A, Camilleri D, Djumanov D Sci Rep. 2021; 11(1):6404.

PMID: 33739022 PMC: 7973531. DOI: 10.1038/s41598-021-85650-3.


No QTc Prolongation With Zanubrutinib: Results of Concentration-QTc Analysis From a Thorough QT Study in Healthy Subjects.

Mu S, Darpo B, Tang Z, Novotny W, Tawashi M, Xue H Clin Transl Sci. 2020; 13(5):923-931.

PMID: 32144955 PMC: 7485941. DOI: 10.1111/cts.12779.


Drug-Induced QT/QTc Interval Shortening: Lessons from Drug-Induced QT/QTc Prolongation.

Malik M Drug Saf. 2016; 39(7):647-59.

PMID: 26968542 DOI: 10.1007/s40264-016-0411-3.


References
1.
Yamada S, Kuga K, Yamaguchi I . Torsade de pointes induced by intravenous and long-term oral amiodarone therapy in a patient with dilated cardiomyopathy. Jpn Circ J. 2001; 65(3):236-8. DOI: 10.1253/jcj.65.236. View

2.
Saumarez R, Grace A . Paced ventricular electrogram fractionation and sudden death in hypertrophic cardiomyopathy and other non-coronary heart diseases. Cardiovasc Res. 2000; 47(1):11-22. DOI: 10.1016/s0008-6363(00)00096-1. View

3.
Kolo P, Opadijo O, Omotoso A, Balogun M, Araoye M, Katibi I . Prevalence of QTc prolongation in adult Nigerians with chronic heart failure. West Afr J Med. 2008; 27(2):69-73. View

4.
Malik M, Camm A . Evaluation of drug-induced QT interval prolongation: implications for drug approval and labelling. Drug Saf. 2001; 24(5):323-51. DOI: 10.2165/00002018-200124050-00001. View

5.
Honig P, Wortham D, Zamani K, Conner D, Mullin J, Cantilena L . Terfenadine-ketoconazole interaction. Pharmacokinetic and electrocardiographic consequences. JAMA. 1993; 269(12):1513-8. View